Simnotrelvir shortens time to resolution of symptoms in COVID-19
Jan 18, 2024
On day 5, the decrease in viral load from baseline was greater in the simnotrelvir group versus the placebo group.
Updated immunization schedule presented for adults for 2024
Jan 11, 2024
The changes include a recommendation for all adults to receive a dose of the new COVID-19 vaccine and RSV vaccination.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
COVID-19 virus no match for lasers, scientists find
By
Aaron Dorman
Jan 11, 2024
A research team using lasers has found that specific wavelengths can do serious damage to either the RNA or protein structures within COVID.
Education, leadership keys to combating vaccine hesitancy in senior living, experts say
By
Kimberly Bonvissuto
Jan 10, 2024
Increasing COVID-19, influenza and respiratory vaccination rates in older adults is going to require a village to battle vaccine reluctance in the form of misinformation, hesitancy and fatigue, according...
Biden looks to boost supply chain for vaccines and other medicines
By
Kathleen Steele Gaivin
Nov 29, 2023
President Biden on Monday said he plans to use the Defense Production Act to make more “essential medicines” in America in an effort to mitigate drug shortages and curb inflation.
Are filters and germicidal lights actually useful? New study hopes to clear the air about them
By
Kristen Fischer
Aaron Dorman
Nov 21, 2023
A new study says air filtration systems can’t stop people from getting viral infections, according to new research.
Virologic rebound occurs in ~20 percent receiving nirmatrelvir-nitonavir
Nov 14, 2023
Virologic rebound was more common among those who started therapy within two days of symptom onset.
Bill would ban COVID-19 vaccine mandates despite older adults remaining at highest risk for serious outcomes
By
Kimberly Bonvissuto
Nov 02, 2023
A study underscoring the need to continue to protect older adults from COVID-19 comes as one state appears close to banning COVID-19 vaccine mandates by private employers, including senior living communities.
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.